The DOI matches its Crossref record.
Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Technology of mammalian cell encapsulation
Uludag, H., De Vos, P., & Tresco, P. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00053-3 · Cited by 601
Host response to tissue engineered devices
Babensee, J. E., Anderson, J. M., McIntire, L. V., & Mikos, A. G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00023-4 · Cited by 585
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Polymer Scaffolds for Biomaterials Applications
Shoichet, M. S. (2010) · Macromolecules · doi:10.1021/ma901530r · Cited by 468
Lepore, A. C., Rauck, B., Dejea, C., Pardo, A. C., Rao, M. S., Rothstein, J. D., & Maragakis, N. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2210 · Cited by 441
Biomaterials for promoting brain protection, repair and regeneration
Orive, G., Anitua, E., Pedraz, J. L., & Emerich, D. F. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2685 · Cited by 421
Thoenen, H., & Sendtner, M. (2002) · Nature Neuroscience · doi:10.1038/nn938 · Cited by 336
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305
“This formulation was found to be devoid of any immune response and cytotoxic effect (Aebischer et al., 1996).”
BackgroundDelivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
Elson, G. C. A., Lelièvre, E., Guillet, C., Chevalier, S., Plun-Favreau, H., Froger, J., Suard, I., de Coignac, A. B., Delneste, Y., Bonnefoy, J.-Y., et al. (2000) · Nature Neuroscience · doi:10.1038/78765 · Cited by 252
Cytokines which signal through the LIF receptor and their actions in the nervous system
Murphy, M., Dutton, R., Koblar, S., Cheema, S., & Bartlett, P. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00020-8 · Cited by 138
Bartus, R. T., & Johnson, E. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.027 · Cited by 97
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Singh, A. V., Khare, M., Gade, W. N., & Zamboni, P. (2012) · Autoimmune Diseases · doi:10.1155/2012/160830 · Cited by 58
Sirianni, R. W., Olausson, P., Chiu, A. S., Taylor, J. R., & Saltzman, W. M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.041 · Cited by 51
Lathuiliere, A., Vernet, R., Charrier, E., Urwyler, M., Von Rohr, O., Belkouch, M.-C., Saingier, V., Bouvarel, T., Guillarme, D., Engel, A., et al. (2022) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.017 · Cited by 14
Metadata
- Authors
- Aebischer, P., Schluep, M., Déglon, N., Joseph, J.-M., Hirt, L., Heyd, B., Goddard, M., Hammang, J. P., Zurn, A. D., Kato, A. C., Regli, F., & Baetge, E. E.
- Venue
- Nature Medicine
- Published
- 1996-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 696-699
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2164587556
- Cited by
- 446
- References
- 0
- FWCI
- 28.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
